Moderna, Inc. (MRNA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Moderna, Inc. reported revenue of $1.94B, down 39.9% from the prior year. The company ran a net loss, with a net margin of -145.2%. It held $12.34B in total assets against $3.69B in total liabilities.
Key ratios (FY2025)
-158.1%
Operating margin
-145.2%
Net margin
-32.6%
Return on equity
-39.9%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.94B | $3.24B | $6.85B | $19.26B | $18.47B | — | $60.21M | — | — | — |
| Cost of Revenue | $868.00M | $1.46B | $4.69B | $5.42B | $2.62B | $8.00M | $0 | $0 | — | — |
| Operating Income | -$3.07B | -$3.94B | -$4.24B | $9.42B | $13.30B | -$763.00M | -$546.00M | -$413.27M | -$269.36M | -$223.77M |
| Net Income | -$2.82B | -$3.56B | -$4.71B | $8.36B | $12.20B | -$747.00M | -$514.00M | -$384.73M | -$255.92M | -$216.21M |
| EPS (Diluted) | $-7.26 | $-9.28 | $-12.33 | $20.12 | $28.29 | $-1.96 | $-1.55 | — | — | — |
| Total Assets | $12.34B | $14.14B | $18.43B | $25.86B | $24.67B | $7.34B | $1.59B | $1.96B | $1.08B | — |
| Total Liabilities | $3.69B | $3.24B | $4.57B | $6.74B | $10.52B | $4.78B | $414.61M | $431.91M | $459.19M | — |
| Shareholders' Equity | $8.65B | $10.90B | $13.85B | $19.12B | $14.14B | $2.56B | $1.18B | $1.53B | -$551.37M | -$334.81M |
| Cash & Equivalents | $2.60B | $1.93B | $2.91B | $3.21B | $6.85B | $2.62B | $236.00M | $658.36M | $134.86M | $50.08M |
| Operating Cash Flow | -$1.87B | -$3.00B | -$3.12B | $4.98B | $13.62B | $2.03B | -$459.00M | -$330.87M | -$331.48M | $66.73M |
| Capital Expenditures | $192.00M | $1.05B | $707.00M | $400.00M | $284.00M | $68.00M | $32.00M | $105.77M | $58.40M | $33.14M |
| Shares Outstanding | 394.00M | 386.00M | 382.00M | 385.00M | 403.00M | 399.00M | 336.54M | 328.80M | 65.21M | — |